Agios Invest Information

Cantor Fitzgerald Reaffirms Overweight Rating on Agios Pharmaceuticals Dec 18, 2024

Agios Pharmaceuticals AGIO Braces for Potential Decline in Q4 Earnings Feb 9, 2024